WJ05129
/ Wigen Biomedicine, Shanghai Junshi Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 03, 2025
A Study of WJ05129 in Advanced Malignant Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=26 | Terminated | Sponsor: Suzhou Junjing BioSciences Co., Ltd. | N=126 ➔ 26 | Not yet recruiting ➔ Terminated; The sponsor terminated the study on the basis of the current data and the company's research and development strategy
Enrollment change • Trial termination • Breast Cancer • Lung Cancer • Small Cell Lung Cancer • Solid Tumor • Triple Negative Breast Cancer • MYC
April 13, 2022
A Study of WJ05129 in Advanced Malignant Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=126 | Not yet recruiting | Sponsor: Suzhou Junjing BioSciences Co., Ltd.
New P1/2 trial • Breast Cancer • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor • Triple Negative Breast Cancer • MYC
1 to 2
Of
2
Go to page
1